Ryan Schoenfeld was named chief executive officer of The Mark Foundation for Cancer Research. Schoenfeld will oversee the foundation’s scientific programs, investments, and operations, and will be responsible for shaping how The Mark Foundation allocates the $500 million in additional funding recently committed by its founder (The Cancer Letter, Feb. 18, 2022).
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
